Amedeo Smart

Free Medical Literature Service


 

Amedeo

Alzheimer's Disease

  Free Subscription

Articles published in
J Neurosci
    November 2021

  1. Erratum: Medeiros et al., "Connecting TNF-alpha Signaling Pathways to iNOS Expression in a Mouse Model of Alzheimer's Disease: Relevance for the Behavioral and Synaptic Deficits Induced by Amyloid beta Protein".
    J Neurosci. 2021 Nov 17. pii: JNEUROSCI.2000-21.2021.
    >> Share


  2. Erratum: Wang et al., "Reducing Amyloid-Related Alzheimer's Disease Pathogenesis by a Small Molecule Targeting Filamin A".
    J Neurosci. 2021 Nov 10. pii: JNEUROSCI.2154-21.2021.
    >> Share

    August 2021
  3. WU M, Liu CZ, Barrall EA, Rissman RA, et al
    Unbalanced regulation of alpha7 nAChRs by Ly6h and NACHO contributes to neurotoxicity in Alzheimer's disease.
    J Neurosci. 2021 Aug 26. pii: JNEUROSCI.0494-21.2021.
    >> Share

    May 2021
  4. OAKLEY DH, Klickstein N, Commins C, Chung M, et al
    Continuous Monitoring of Tau-Induced Neurotoxicity in Patient-Derived iPSC-Neurons.
    J Neurosci. 2021;41:4335-4348.
    >> Share

  5. SALAMONE PC, Legaz A, Sedeno L, Moguilner S, et al
    Interoception Primes Emotional Processing: Multimodal Evidence from Neurodegeneration.
    J Neurosci. 2021;41:4276-4292.
    >> Share

  6. TAKAMURA R, Mizuta K, Sekine Y, Islam T, et al
    Modality specific impairment of hippocampal CA1 neurons of Alzheimer's disease model mice.
    J Neurosci. 2021 May 10. pii: JNEUROSCI.0208-21.2021.
    >> Share

  7. GOODMAN AM, Langner BM, Jackson N, Alex C, et al
    Heightened hippocampal beta-adrenergic receptor function drives synaptic potentiation and supports learning and memory in the TgF344-AD rat model during prodromal Alzheimer's disease.
    J Neurosci. 2021 May 5. pii: JNEUROSCI.0119-21.2021.
    >> Share

    April 2021
  8. ADAMS JN, Maass A, Berron D, Harrison TM, et al
    Reduced Repetition Suppression in Aging is Driven by Tau-Related Hyperactivity in Medial Temporal Lobe.
    J Neurosci. 2021;41:3917-3931.
    >> Share

  9. VAN SKIKE CE, Hussong SA, Hernandez SF, Banh AQ, et al
    mTOR attenuation with rapamycin reverses neurovascular uncoupling and memory deficits in mice modeling Alzheimer's disease.
    J Neurosci. 2021 Apr 20. pii: JNEUROSCI.2144-20.2021.
    >> Share

    March 2021
  10. MORENO-JIMENEZ EP, Terreros-Roncal J, Flor-Garcia M, Rabano A, et al
    Evidences for Adult Hippocampal Neurogenesis in Humans.
    J Neurosci. 2021;41:2541-2553.
    >> Share

    February 2021
  11. SANCHEZ-AGUILERA A, Quintanilla JP
    Sharp Wave Ripples in Alzheimer's Disease: In Search of Mechanisms.
    J Neurosci. 2021;41:1366-1370.
    >> Share

  12. RIVERS-AUTY J, Tapia VS, White CS, Daniels MJ, et al
    Zinc status alters Alzheimer's disease progression through NLRP3-dependent inflammation.
    J Neurosci. 2021 Feb 16. pii: JNEUROSCI.1980-20.2020.
    >> Share

    November 2020
  13. FRACASSI A, Marcatti M, Zolochevska O, Tabor N, et al
    Oxidative damage and antioxidant response in frontal cortex of demented and non-demented individuals with Alzheimer's neuropathology.
    J Neurosci. 2020 Nov 24. pii: JNEUROSCI.0295-20.2020.
    >> Share

    October 2020
  14. ALBRECHT D, Isenberg AL, Stradford J, Monreal T, et al
    Associations between Vascular Function and Tau PET Are Associated with Global Cognition and Amyloid.
    J Neurosci. 2020;40:8573-8586.
    >> Share


  15. Erratum: Forny-Germano et al., "Alzheimer's Disease-Like Pathology Induced by Amyloid-beta Oligomers in Nonhuman Primates".
    J Neurosci. 2020 Oct 6. pii: JNEUROSCI.1827-20.2020.
    >> Share

    September 2020
  16. CHEN W, Wang M, Zhu M, Xiong W, et al
    14,15-epoxyeicosatrienoic acid alleviates pathology in a mouse model of Alzheimer's disease.
    J Neurosci. 2020 Sep 24. pii: JNEUROSCI.1246-20.2020.
    >> Share

  17. ZHANG H, Lin A, Gong P, Chen Y, et al
    The Chemokine-like Receptor 1 Deficiency Improves Cognitive Deficits of AD Mice and Attenuates Tau Hyperphosphorylation via Regulating Tau Seeding.
    J Neurosci. 2020;40:6991-7007.
    >> Share

    August 2020
  18. GHALAYINI J
    Exploring the Therapeutic Potential of Protein Tyrosine Phosphatase 1B in hAPP-J20 Mouse Model of Alzheimer's Disease.
    J Neurosci. 2020;40:6100-6102.
    >> Share

    July 2020
  19. ZHANG H, Chen W, Tan Z, Zhang L, et al
    A Role of Low-Density Lipoprotein Receptor-Related Protein 4 (LRP4) in Astrocytic Abeta Clearance.
    J Neurosci. 2020;40:5347-5361.
    >> Share

    May 2020
  20. SHEYNIN Y, Rosa-Neto P, Hess RF, Vaucher E, et al
    Cholinergic modulation of binocular vision.
    J Neurosci. 2020 May 25. pii: JNEUROSCI.2484-19.2020.
    >> Share

  21. CACCAVANO A, Bozzelli PL, Forcelli PA, Pak DTS, et al
    Inhibitory parvalbumin basket cell activity is selectively reduced during hippocampal sharp wave ripples in a mouse model of familial Alzheimer's disease.
    J Neurosci. 2020 May 21. pii: JNEUROSCI.0425-20.2020.
    >> Share

    April 2020
  22. SHIMOJO M, Takuwa H, Takado Y, Tokunaga M, et al
    Selective Disruption of Inhibitory Synapses Leading to Neuronal Hyperexcitability at an Early Stage of Tau Pathogenesis in a Mouse Model.
    J Neurosci. 2020;40:3491-3501.
    >> Share

    February 2020
  23. ONUSKA KM
    The Dual Role of Microglia in the Progression of Alzheimer's Disease.
    J Neurosci. 2020;40:1608-1610.
    >> Share

    January 2020
  24. MEILANDT WJ, Ngu H, Gogineni A, Lalehzadeh G, et al
    Trem2 deletion reduces late-stage amyloid plaque accumulation, elevates the Abeta42:Abeta40 ratio, and exacerbates axonal dystrophy and dendritic spine loss in the PS2APP Alzheimer's mouse model.
    J Neurosci. 2020 Jan 24. pii: JNEUROSCI.1871-19.2019.
    >> Share

  25. SCHMITZ TW, Soreq H, Poirier J, Spreng RN, et al
    Longitudinal basal forebrain degeneration interacts with TREM2/C3 biomarkers of inflammation in pre-symptomatic Alzheimer's disease.
    J Neurosci. 2020 Jan 8. pii: JNEUROSCI.1184-19.2019.
    >> Share

  26. RICKE KM, Cruz SA, Qin Z, Farrokhi K, et al
    Neuronal Protein Tyrosine Phosphatase 1B hastens Amyloid beta-associated Alzheimer's disease in mice.
    J Neurosci. 2020 Jan 8. pii: JNEUROSCI.2120-19.2019.
    >> Share

    December 2019
  27. FAN Q, He W, Gayen M, Robert Benoit M, et al
    Activated CX3CL1/Smad2 signals prevent neuronal loss and Alzheimer's tau pathology-mediated cognitive dysfunction.
    J Neurosci. 2019 Dec 10. pii: JNEUROSCI.1333-19.2019.
    >> Share

  28. CHENG A, Wang J, Ghena N, Zhao Q, et al
    SIRT3 Haploinsufficiency Aggravates Loss of GABAergic Interneurons and Neuronal Network Hyperexcitability in an Alzheimer's Disease Model.
    J Neurosci. 2019 Dec 9. pii: JNEUROSCI.1446-19.2019.
    >> Share

    October 2019
  29. LEI M, Teo JD, Song H, McEwen HP, et al
    Sphingosine kinase 2 potentiates amyloid deposition but protects against hippocampal volume loss and demyelination in a mouse model of Alzheimer's disease.
    J Neurosci. 2019 Oct 21. pii: JNEUROSCI.0524-19.2019.
    >> Share

    September 2019
  30. SINGH A, Jones OD, Mockett BG, Ohline SM, et al
    Tumor Necrosis Factor-alpha-Mediated Metaplastic Inhibition of LTP is Constitutively Engaged in an Alzheimer's Disease Model.
    J Neurosci. 2019 Sep 30. pii: JNEUROSCI.1492-19.2019.
    >> Share

    January 2019
  31. HUIJBERS W, Schultz AP, Papp KV, LaPoint MR, et al
    Tau Accumulation in Clinically Normal Older Adults Is Associated with Hippocampal Hyperactivity.
    J Neurosci. 2019;39:548-556.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016